What is Akari Therapeutics plc ADR (0.01 USD)'s Market Cap?

Akari Therapeutics plc ADR (0.01 USD)'s Market Cap is $1.7T, based on as-reported figures from SEC (XBRL) filings.

What is Akari Therapeutics plc ADR (0.01 USD)'s Enterprise Value?

Akari Therapeutics plc ADR (0.01 USD)'s Enterprise Value is $1.7T, based on as-reported figures from SEC (XBRL) filings.

What is Akari Therapeutics plc ADR (0.01 USD)'s EV / EBITDA?

Akari Therapeutics plc ADR (0.01 USD)'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Akari Therapeutics plc ADR (0.01 USD)'s Net Income (TTM)?

Akari Therapeutics plc ADR (0.01 USD)'s Net Income (TTM) is -$31.0M, based on as-reported figures from SEC (XBRL) filings.

What is Akari Therapeutics plc ADR (0.01 USD)'s EBITDA?

Akari Therapeutics plc ADR (0.01 USD)'s EBITDA is -$31.0M, based on as-reported figures from SEC (XBRL) filings.

What is Akari Therapeutics plc ADR (0.01 USD)'s Diluted EPS (TTM)?

Akari Therapeutics plc ADR (0.01 USD)'s Diluted EPS (TTM) is -0.00, based on as-reported figures from SEC (XBRL) filings.

What is Akari Therapeutics plc ADR (0.01 USD)'s Net Debt?

Akari Therapeutics plc ADR (0.01 USD)'s Net Debt is -$7.7M, based on as-reported figures from SEC (XBRL) filings.

Akari Therapeutics plc ADR (0.01 USD) (AKTX) Financial Statements

Akari Therapeutics plc ADR (0.01 USD)

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG003PMV510

XNAS · usd

10.96▼ 0.51 (-4.45%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close11.47

Day's Range10.75 – 12.04

52-Week Range0.12 – 29.32

Volume128.5K

Avg Volume64.6K

Share Statistics

Shares Outstanding

Employees5

ExchangeXNAS

Listed2012-12-07

Share count as of August 13, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Akari Therapeutics plc ADR (0.01 USD) (AKTX)

What is Akari Therapeutics plc ADR (0.01 USD)'s Market Cap?: Akari Therapeutics plc ADR (0.01 USD)'s Market Cap is $1.7T, based on as-reported figures from SEC (XBRL) filings.
What is Akari Therapeutics plc ADR (0.01 USD)'s Enterprise Value?: Akari Therapeutics plc ADR (0.01 USD)'s Enterprise Value is $1.7T, based on as-reported figures from SEC (XBRL) filings.
What is Akari Therapeutics plc ADR (0.01 USD)'s EV / EBITDA?: Akari Therapeutics plc ADR (0.01 USD)'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Akari Therapeutics plc ADR (0.01 USD)'s Net Income (TTM)?: Akari Therapeutics plc ADR (0.01 USD)'s Net Income (TTM) is -$31.0M, based on as-reported figures from SEC (XBRL) filings.
What is Akari Therapeutics plc ADR (0.01 USD)'s EBITDA?: Akari Therapeutics plc ADR (0.01 USD)'s EBITDA is -$31.0M, based on as-reported figures from SEC (XBRL) filings.
What is Akari Therapeutics plc ADR (0.01 USD)'s Diluted EPS (TTM)?: Akari Therapeutics plc ADR (0.01 USD)'s Diluted EPS (TTM) is -0.00, based on as-reported figures from SEC (XBRL) filings.
What is Akari Therapeutics plc ADR (0.01 USD)'s Net Debt?: Akari Therapeutics plc ADR (0.01 USD)'s Net Debt is -$7.7M, based on as-reported figures from SEC (XBRL) filings.